Gene: Gprin1 (G protein-regulated inducer of neurite outgrowth 1) Rattus norvegicus
Analyze
Symbol:
Gprin1
Name:
G protein-regulated inducer of neurite outgrowth 1
Description:
Predicted to have phosphoprotein binding activity. Predicted to be involved in neuron projection development. Predicted to localize to the plasma membrane. Orthologous to human GPRIN1 (G protein regulated inducer of neurite outgrowth 1); INTERACTS WITH 6-propyl-2-thiouracil; bisphenol A; C60 fullerene.
Type:
protein-coding
RefSeq Status:
MODEL
Also known as:
LOC364676; LOW QUALITY PROTEIN: G protein-regulated inducer of neurite outgrowth 1
Orthologs:
Latest Assembly:
Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Rnor_6.0 17 10,411,129 - 10,415,023 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 17 10,411,273 - 10,414,016 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 17 12,537,071 - 12,540,882 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 17 15,934,093 - 15,937,281 (+) NCBI RGSC3.4 rn4 RGSC3.4 RGSC_v3.1 17 15,924,550 - 15,936,948 (+) NCBI Celera 17 9,948,096 - 9,950,986 (+) NCBI Celera Cytogenetic Map 17 p14 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Gene-Chemical Interaction Annotations
17beta-estradiol multiple interactions ISO RGD:1606183 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of GPRIN1 mRNA CTD PMID:30165855 2,3,7,8-tetrabromodibenzodioxine increases expression ISO RGD:1318723 6480464 2 more ... CTD PMID:27604104 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318723 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to GPRIN1 promoter] CTD PMID:19654925 2-methylcholine affects expression ISO RGD:1606183 6480464 beta-methylcholine affects the expression of GPRIN1 mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol decreases expression ISO RGD:1318723 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of GPRIN1 mRNA CTD PMID:30951980 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of GPRIN1 mRNA CTD PMID:24780913 arsane increases expression ISO RGD:1318723 6480464 Arsenic results in increased expression of GPRIN1 protein CTD PMID:22552367 arsenic atom increases expression ISO RGD:1318723 6480464 Arsenic results in increased expression of GPRIN1 protein CTD PMID:22552367 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of GPRIN1 mRNA CTD PMID:25181051 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GPRIN1 mRNA CTD PMID:30816183 butanal decreases expression ISO RGD:1606183 6480464 butyraldehyde results in decreased expression of GPRIN1 mRNA CTD PMID:26079696 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of GPRIN1 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO RGD:1606183 6480464 Cadmium Chloride results in increased expression of GPRIN1 protein CTD PMID:26220685 cisplatin multiple interactions ISO RGD:1606183 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of GPRIN1 mRNA CTD PMID:27392435 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of GPRIN1 mRNA CTD PMID:23640034 dicrotophos increases expression ISO RGD:1606183 6480464 dicrotophos results in increased expression of GPRIN1 mRNA CTD PMID:28302478 endosulfan increases expression ISO RGD:1606183 6480464 Endosulfan results in increased expression of GPRIN1 protein CTD PMID:26722802 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPRIN1 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of GPRIN1 mRNA CTD PMID:22129741 paracetamol increases expression ISO RGD:1606183 6480464 Acetaminophen results in increased expression of GPRIN1 mRNA CTD PMID:29067470 potassium dichromate increases expression ISO RGD:1318723 6480464 Potassium Dichromate results in increased expression of GPRIN1 mRNA CTD PMID:23608068 resveratrol increases expression ISO RGD:1606183 6480464 resveratrol results in increased expression of GPRIN1 mRNA CTD PMID:25436977 Soman decreases expression EXP 6480464 Soman results in decreased expression of GPRIN1 mRNA CTD PMID:19281266 tunicamycin decreases expression ISO RGD:1606183 6480464 Tunicamycin results in decreased expression of GPRIN1 mRNA CTD PMID:22378314 urethane increases expression ISO RGD:1606183 6480464 Urethane results in increased expression of GPRIN1 mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:1318723 6480464 Valproic Acid results in increased expression of GPRIN1 mRNA CTD PMID:21427059 valproic acid increases methylation ISO RGD:1606183 6480464 Valproic Acid results in increased methylation of GPRIN1 gene CTD PMID:29154799
Gene Ontology Annotations
9590316 Scort21 Serum corticosterone level QTL 21 4.75 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 17 1 24787908 Rat 10401807 Kidm52 Kidney mass QTL 52 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 17 1 32230361 Rat 70184 BpQTLcluster14 Blood pressure QTL cluster 14 3.38 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 17 1 33303755 Rat 631207 Niddm41 Non-insulin dependent diabetes mellitus QTL 41 blood glucose amount (VT:0000188) plasma glucose level (CMO:0000042) 17 1 38243814 Rat 1354658 Spl8 Serum phospholipid level QTL 8 3.8 blood VLDL phospholipid amount (VT:0010507) blood very low density lipoprotein phospholipid level (CMO:0001571) 17 1 63676140 Rat 1354662 Rf49 Renal function QTL 49 2.9 blood creatinine amount (VT:0005328) plasma creatinine level (CMO:0000537) 17 1 73413148 Rat 1354581 Bp247 Blood pressure QTL 247 4.5 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 17 1 73413148 Rat 1641902 Colcr7 Colorectal carcinoma resistance QTL 7 3.35 0.0044 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 17 519770 23422380 Rat 1300123 Bp194 Blood pressure QTL 194 2.82 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 17 519770 36283402 Rat 2324619 Coatc4 Coat color QTL 4 0.001 coat/hair pigmentation trait (VT:0010463) pigmented coat/hair area to total coat/hair area ratio (CMO:0001810) 17 3336972 24030841 Rat 2324619 Coatc4 Coat color QTL 4 0.001 coat/hair pigmentation trait (VT:0010463) pigmented dorsal coat/hair area to total dorsal coat/hair area ratio (CMO:0001811) 17 3336972 24030841 Rat 1354613 Kidm14 Kidney mass QTL 14 6.2 kidney mass (VT:0002707) left kidney wet weight (CMO:0000083) 17 3336972 37790462 Rat 1354596 Bw32 Body weight QTL 32 4.5 body mass (VT:0001259) body weight (CMO:0000012) 17 3336972 63676140 Rat 1354638 Insul1 Insulin level QTL 1 4.8 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 17 3336972 73413148 Rat 1354651 Lmblg2 Limb length QTL 2 6 tibia length (VT:0004357) tibia length (CMO:0000450) 17 3336972 73413148 Rat 1354630 Cm34 Cardiac mass QTL 34 8.7 heart left ventricle mass (VT:0007031) heart left ventricle wet weight (CMO:0000071) 17 3336972 73413148 Rat 631499 Stl1 Serum triglyceride level QTL 1 3.6 blood triglyceride amount (VT:0002644) blood triglyceride level (CMO:0000118) 17 3414039 28073589 Rat 2293648 Bmd31 Bone mineral density QTL 31 4.5 0.0001 femur size trait (VT:1000369) femoral neck cortical cross-sectional area (CMO:0001702) 17 4716067 27691136 Rat 2293664 Bmd28 Bone mineral density QTL 28 5.1 0.0001 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 17 4716067 27691136 Rat 2303627 Vencon8 Ventilatory control QTL 8 0.001 respiration trait (VT:0001943) tidal volume (CMO:0000222) 17 5191047 50191047 Rat 10054088 Scort28 Serum corticosterone level QTL 28 2.04 0.0102 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 17 5191047 50191047 Rat 1581553 Pur14 Proteinuria QTL 14 5.3 0.0001 total urine protein amount (VT:0000032) urine protein excretion rate (CMO:0000759) 17 8424467 16620067 Rat 1582224 Epfw4 Epididymal fat weight QTL 4 3.5 0.0058 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 17 9730263 21491085 Rat 1582225 Bw67 Body weight QTL 67 6.2 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 17 9730263 21491085 Rat 1582226 Bw64 Body weight QTL 64 4.2 0.0017 body mass (VT:0001259) body weight (CMO:0000012) 17 9730263 21491085 Rat 1582241 Bw70 Body weight QTL 70 4.6 0.0003 body mass (VT:0001259) body weight (CMO:0000012) 17 9730263 21491085 Rat 1582245 Bw73 Body weight QTL 73 4.6 0.0004 body mass (VT:0001259) body weight (CMO:0000012) 17 9730263 21491085 Rat 1582258 Bw76 Body weight QTL 76 4.6 0.0005 body mass (VT:0001259) body weight (CMO:0000012) 17 9730263 21491085 Rat 1582199 Insul5 Insulin level QTL 5 3.4 0.0119 blood insulin amount (VT:0001560) calculated serum insulin level (CMO:0000359) 17 9730263 21491085 Rat 1582208 Kidm32 Kidney mass QTL 32 3.9 0.0018 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 17 9730263 21491085 Rat 2303561 Bw91 Body weight QTL 91 2 body mass (VT:0001259) body weight (CMO:0000012) 17 9827304 54827304 Rat
Predicted Target Of
Count of predictions: 114 Count of miRNA genes: 95 Interacting mature miRNAs: 102 Transcripts: ENSRNOT00000024258 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
Gene-Chemical Interaction Annotations
